Understand the source comparison
TB-4 Real vs Fake: How to Tell | Real Peptides
Counterfeit TB-4 doesn't announce itself with obvious red flags. Most fake peptides arrive in convincing packaging, dissolve cleanly in bacteriostatic water, and look identical to pharmaceutical-grade material under casual inspection. The problem surfaces week
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Counterfeit TB-4 doesn't announce itself with obvious red flags. Most fake peptides arrive in convincing packaging, dissolve cleanly in bacteriostatic water, and look identical to pharmaceutical-grade material under casual inspection. The problem surfaces weeks into a research protocol when expected cellular migration patterns don't materialize, inflammatory markers fail to shift, or reproducibility collapses across trial replicates. By that point, the damage to your research timeline. And budget. Is done.
- Our team has evaluated peptide sourcing across hundreds of research-grade compounds. The gap between legitimate TB-4 and convincing counterfeits comes down to three things most procurement guides never mention: post-reconstitution clarity, third-party purity documentation that names the testing lab, and vendor response time when you ask for current batch COAs. The rest is theater.
- How do you verify TB-4 authenticity before compromising a research protocol?
- Authentic TB-4 (Thymosin Beta-4) requires third-party HPLC verification showing ≥98% purity, documented molecular weight confirmation via mass spectrometry, and sterility testing through an ISO-certified lab. Visual inspection alone cannot detect underdosing, bacterial contamination, or amino acid sequence errors. The three most common counterfeit patterns in research peptides. Verification depends on COA cross-referencing, not appearance.
- Here's the counterintuitive reality most peptide guides gloss over: price is not the primary authenticity signal. We've seen $180 vials containing accurately dosed TB-4 and $450 vials containing 40% degraded material. The real differentiator is whether the supplier provides batch-specific certificates of analysis from named third-party labs. Not in-house testing, not generic PDFs recycled across products. This article covers the six verification steps legitimate research facilities use, the reconstitution behaviors that reveal degradation, and what peptide synthesis documentation actually proves versus what it claims to prove.